Skip to content
Immunophotonics
  • About
    • Team
    • Board of Directors
    • Advisory Board
    • Highlighted Co-Inventor
    • Collaborators
  • Technology
  • Interventional Immuno-Oncology®
  • Clinical Trials
    • Colorectal Cancer (CRC)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Melanoma
    • Soft Tissue Sarcoma (STS)
    • Hepatocellular Carcinoma (HCC)
    • Pancreatic Cancer
    • Vaccine Adjuvant
  • Patients
  • News & Media
  • Contact Us
Menu

News

404

News & Media

  •          
  • Print
Home » News & Media
Latest News

BIO Investment & Growth Summit – March 2 & 3, 2026

February 27, 2026
Miguel Zubizarreta, CEO, and Robert Arch, President of Immunophotonics, Inc. are gearing up for a presentation with exciting updates at the BIO Investment &…
Read More
Latest News Press Releases

Patent Milestone for Immunophotonics, Inc.

February 24, 2026
Immunophotonics is excited to announce that the European Patent Office has issued a new patent titled “Semi-Synthetic Biopolymers for Use in Stimulating the…
Read More
Latest News

SIO Annual Scientific Meeting, February 4-8, 2026

February 2, 2026
Immunophotonics is attending SIO Scientific Meeting in Savannah, Georgia. Our President, Robert Arch, PhD, and CIO & Co-Founder, Tomas Hode,…
Read More
Latest News

Spectrum Conference, January 15-17, 2026

January 13, 2026
Immunophotonics’ CIO, Tomas Hode, PhD, is attending the Spectrum Conference, January 15–17, in Miami, Florida. This event brings together some…
Read More
Latest News

2026 Annual Summit in San Francisco, January 11-15, 2026

January 7, 2026
Our networking is in full swing for JPM2026! We invite you to meet our team at the 2026 Annual Summit…
Read More
Latest News Press Releases

Immunophotonics Strengthens Leadership with New Board Appointment

November 25, 2025
We are excited to welcome Richard Levenson, M.D. to further strengthen our leadership team as a member of the Board of Directors…
Read More
Latest News

AngioDynamics International Life Symposium November 6–8, 2025

November 3, 2025
Tomas Hode, PhD (Chief Innovation Officer) and Robert Arch, PhD (President) will be representing Immunophotonics at the 8th Biannual AngioDynamics…
Read More
Latest News

BIO-Europe November 3-5, 2025

October 30, 2025
Robert Arch, PhD (President) will be attending BIO-Europe 2025 in Vienna, Austria, November 3-5. As one of the premier partnering…
Read More
Latest News

ThinkEquity Conference – October 30, 2025

October 28, 2025
Robert Arch, PhD (President) at Immunophotonics will be attending the ThinkEquity Conference at the Mandarin Oriental, New York on October 30th. Robert…
Read More
Latest News

Life Sciences Innovation Forum October 1 & 2, 2025

September 29, 2025
Immunophotonics is excited to be part of the Life Sciences Innovation Forum 2025 in Riyadh! Hosted by J.P. Morgan Asset…
Read More
« Previous 1 2 3 4 … 14 Next »
Contact us for more info and updates
  • About
  • Team
  • Board of Directors
  • Advisory Board
  • Highlighted Co-Inventor
  • Collaborators
  • Technology
  • Clinical Trials
  • Colorectal Cancer (CRC)
  • Non-Small Cell Lung Cancer (NSCLC)
  • Melanoma
  • Soft Tissue Sarcoma (STS)
  • Hepatocellular Carcinoma (HCC)
  • Pancreatic Cancer
  • Vaccine Adjuvant
  • Patients
  • Background
  • Trial Summary

Quick Links

  • Interventional Immuno-Oncology®
  • News & Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map
© Immunophotonics, Inc. All Rights Reserved
Terms of Use | FCOI Policy
Website by Axxiem
Scroll to top